nach oben

European Surgery

Erschienen in:

01.06.2013 | Main Topic

Tissue engineered constructs for peripheral nerve surgery

verfasst von: Asst. Prof. P. J. Johnson, PhD, M. D. Wood, PhD, A. M . Moore, MD, S. E. Mackinnon, MD

Erschienen in: European Surgery | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Summary

Background

Tissue engineering has been defined as “an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function or a whole organ”. Traumatic peripheral nerve injury resulting in significant tissue loss at the zone of injury necessitates the need for a bridge or scaffold for regenerating axons from the proximal stump to reach the distal stump.

Methods

A review of the literature was used to provide information on the components necessary for the development of a tissue engineered peripheral nerve substitute. Then, a comprehensive review of the literature is presented composed of the studies devoted to this goal.

Results

Extensive research has been directed toward the development of a tissue engineered peripheral nerve substitute to act as a bridge for regenerating axons from the proximal nerve stump seeking the distal nerve. Ideally this nerve substitute would consist of a scaffold component that mimics the extracellular matrix of the peripheral nerve and a cellular component that serves to stimulate and support regenerating peripheral nerve axons.

Conclusions

The field of tissue engineering should consider its challenge to not only meet the autograft “gold standard” but also to understand what drives and inhibits nerve regeneration in order to surpass the results of an autograft.

Vorheriger Artikel Tissue engineering and its potential use in surgery

Nächster Artikel Applications of tissue engineering in modern laryngology 

Kouyoumdjian JA. Peripheral nerve injuries: a retrospective survey of 456 cases. Muscle Nerve. 2006;34(6):785–8.PubMedCrossRef

Seddon HJ, Medawar PB, Smith H. Rate of regeneration of peripheral nerves in man. J Physiol. 1943;102(2):191–215.PubMed

Xu QG, et al. Motoneuron survival after chronic and sequential peripheral nerve injuries in the rat. J Neurosurg. 2010;112(4):890–9.PubMedCrossRef

Schmalbruch H. Loss of sensory neurons after sciatic nerve section in the rat. Anat Rec. 1987;219(3):323–9.PubMedCrossRef

McKay Hart A, et al. Primary sensory neurons and satellite cells after peripheral axotomy in the adult rat: timecourse of cell death and elimination. Exp Brain Res. 2002;142(3):308–18.PubMedCrossRef

Terenghi G, Hart A, Wiberg M. The nerve injury and the dying neurons: diagnosis and prevention. J Hand Surg Eur Vol. 2011;36(9):730–4.PubMed

West CA, et al. Sensory neurons of the human brachial plexus: a quantitative study employing optical fractionation and in vivo volumetric magnetic resonance imaging. Neurosurgery. 2012;70(5):1183–94.PubMedCrossRef

Fu SY, Gordon T. The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol. 1997;14(1–2):67–116.PubMedCrossRef

Beuche W, Friede RL. The role of nonresident cells in Wallerian degeneration. J Neurocytol. 1984;13(5):767–96.PubMedCrossRef

10.

Scheidt P, Friede RL. Myelin phagocytosis in Wallerian degeneration. Properties of millipore diffusion chambers and immunohistochemical identification of cell populations. Acta Neuropathol. 1987;75(1):77–84.PubMedCrossRef

11.

Bruck W. The role of macrophages in Wallerian degeneration. Brain Pathol. 1997;7(2):741–52.PubMedCrossRef

12.

Witzel C, Rohde C, Brushart TM. Pathway sampling by regenerating peripheral axons. J Comp Neurol. 2005;485(3):183–90.PubMedCrossRef

13.

Millesi H, Meissl G, Berger A. Further experience with interfascicular grafting of the median, ulnar, and radial nerves. J Bone Joint Surg Am. 1976;58(2):209–18.PubMed

14.

Millesi H. Peripheral nerve injuries. Nerve sutures and nerve grafting. Scand J Plast Reconstr Surg Suppl. 1982;19:25–37.

15.

de Medinaceli L, Wyatt RJ, Freed WJ. Peripheral nerve reconnection: mechanical, thermal, and ionic conditions that promote the return of function. Exp Neurol. 1983;81(2):469–87.PubMedCrossRef

16.

Millesi H. Peripheral nerve repair: terminology, questions, and facts. J Reconstr Microsurg. 1985;2(1):21–31.PubMedCrossRef

17.

Chiu DT, Ishii C. Management of peripheral nerve injuries. Orthop Clin North Am. 1986;17(3):365–73.PubMed

18.

Belkas JS, Shoichet MS, Midha R. Peripheral nerve regeneration through guidance tubes. Neurol Res. 2004;26(2):151–60.PubMedCrossRef

19.

Meek MF, Coert JH. Clinical use of nerve conduits in peripheral-nerve repair: review of the literature. J Reconstr Microsurg. 2002;18(2):97–109.PubMedCrossRef

20.

Evans GR. Peripheral nerve injury: a review and approach to tissue engineered constructs. Anat Rec. 2001;263(4):396–404.PubMedCrossRef

21.

Madduri S, Gander B. Growth factor delivery systems and repair strategies for damaged peripheral nerves. J Control Release. 2012;161(2):274–82.PubMedCrossRef

22.

Lundborg G, Hansson HA. Regeneration of peripheral nerve through a preformed tissue space. Preliminary observations on the reorganization of regenerating nerve fibres and perineurium. Brain Res. 1979;178(2–3):573–6.PubMedCrossRef

23.

Lundborg G, Hansson HA. Nerve regeneration through preformed pseudosynovial tubes. A preliminary report of a new experimental model for studying the regeneration and reorganization capacity of peripheral nerve tissue. J Hand Surg Am. 1980;5(1):35–8.PubMed

24.

Lundborg G, et al. Reorganization and orientation of regenerating nerve fibres, perineurium, and epineurium in preformed mesothelial tubes—an experimental study on the sciatic nerve of rats. J Neurosci Res. 1981;6(3):265–81.PubMedCrossRef

25.

Lundborg G, et al. Nerve regeneration in silicone chambers: influence of gap length and of distal stump components. Exp Neurol. 1982;76(2):361–75.PubMedCrossRef

26.

Merle M, et al. Complications from silicon-polymer intubulation of nerves. Microsurgery. 1989;10(2):130–3.PubMedCrossRef

27.

Dellon AL. Use of a silicone tube for the reconstruction of a nerve injury. J Hand Surg Br. 1994;19(3):271–2.PubMedCrossRef

28.

Battiston B, et al. Nerve repair by means of tubulization: literature review and personal clinical experience comparing biological and synthetic conduits for sensory nerve repair. Microsurgery. 2005;25(4):258–67.PubMedCrossRef

29.

Hadlock T, et al. A tissue-engineered conduit for peripheral nerve repair. Arch Otolaryngol Head Neck Surg. 1998;124(10):1081–6.PubMed

30.

Nicoli Aldini N, et al. Effectiveness of a bioabsorbable conduit in the repair of peripheral nerves. Biomaterials. 1996;17(10):959–62.PubMedCrossRef

31.

Archibald SJ, et al. A collagen-based nerve guide conduit for peripheral nerve repair: an electrophysiological study of nerve regeneration in rodents and nonhuman primates. J Comp Neurol. 1991;306(4):685–96.PubMedCrossRef

32.

Li ST, et al. Peripheral nerve repair with collagen conduits. Clin Mater. 1992;9(3–4):195–200.PubMedCrossRef

33.

Whitworth IH, et al. Orientated mats of fibronectin as a conduit material for use in peripheral nerve repair. J Hand Surg Br. 1995;20(4):429–36.PubMedCrossRef

34.

Kalbermatten DF, et al. New fibrin conduit for peripheral nerve repair. J Reconstr Microsurg. 2009;25(1):27–33.PubMedCrossRef

35.

Pfister BJ, et al. Biomedical engineering strategies for peripheral nerve repair: surgical applications, state of the art, and future challenges. Crit Rev Biomed Eng. 2011;39(2):81–124.PubMedCrossRef

36.

Lundborg G, Dahlin LB, Danielsen N. Ulnar nerve repair by the silicone chamber technique. Case report. Scand J Plast Reconstr Surg Hand Surg. 1991;25(1):79–82.PubMedCrossRef

37.

Lundborg G, et al. Tubular repair of the median nerve in the human forearm. Preliminary findings. J Hand Surg Br. 1994;19(3):273–6.PubMedCrossRef

38.

Lundborg G, et al. Tubular versus conventional repair of median and ulnar nerves in the human forearm: early results from a prospective, randomized, clinical study. J Hand Surg Am. 1997;22(1):99–106.PubMedCrossRef

39.

Lundborg G, et al. Tubular repair of the median or ulnar nerve in the human forearm: a 5-year follow-up. J Hand Surg Br. 2004;29(2):100–7.PubMedCrossRef

40.

Moore AM, et al. Limitations of conduits in peripheral nerve repairs. Hand (N Y). 2009;4(2):180–6.CrossRef

41.

Mackinnon SE. Technical use of synthetic conduits for nerve repair. J Hand Surg Am. 2011;36(1):183.PubMedCrossRef

42.

Kehoe S, Zhang XF, Boyd D. FDA approved guidance conduits and wraps for peripheral nerve injury: A review of materials and efficacy. Injury. 2012;43(5):553–72.PubMedCrossRef

43.

Johnson PJ, et al. Nerve endoneurial microstructure facilitates uniform distribution of regenerative fibers: a post hoc comparison of midgraft nerve fiber densities. J Reconstr Microsurg. 2011;27(2):83–90.PubMedCrossRef

44.

Lloyd BM, et al. Use of motor nerve material in peripheral nerve repair with conduits. Microsurgery. 2007;27(2):138–45.PubMedCrossRef

45.

Lundborg G, et al. Nerve regeneration across an extended gap: a neurobiological view of nerve repair and the possible involvement of neuronotrophic factors. J Hand Surg Am. 1982;7(6):580–7.PubMed

46.

Madison RD, et al. Peripheral nerve regeneration with entubulation repair: comparison of biodegradeable nerve guides versus polyethylene tubes and the effects of a laminin-containing gel. Exp Neurol. 1987;95(2):378–90.PubMedCrossRef

47.

Madison RD, Da Silva CF, Dikkes P. Entubulation repair with protein additives increases the maximum nerve gap distance successfully bridged with tubular prostheses. Brain Res. 1988;447(2):325–34.PubMedCrossRef

48.

Madison RD, Archibald SJ. Point sources of Schwann cells result in growth into a nerve entubulation repair site in the absence of axons: effects of freeze-thawing. Exp Neurol. 1994;128(2):266–75.PubMedCrossRef

49.

Williams LR. Exogenous fibrin matrix precursors stimulate the temporal progress of nerve regeneration within a silicone chamber. Neurochem Res. 1987;12(10):851–60.PubMedCrossRef

50.

Wood MD, Sakiyama-Elbert SE. Release rate controls biological activity of nerve growth factor released from fibrin matrices containing affinity-based delivery systems. J Biomed Mater Res A. 2008;84(2):300–12.PubMed

51.

Wood MD, Borschel GH, Sakiyama-Elbert SE. Controlled release of glial-derived neurotrophic factor from fibrin matrices containing an affinity-based delivery system. J Biomed Mater Res A. 2009;89(4):909–18.PubMed

52.

Wood MD, et al. Affinity-based release of glial-derived neurotrophic factor from fibrin matrices enhances sciatic nerve regeneration. Acta Biomater. 2009;5(4):959–68.PubMedCrossRef

53.

Wood MD, et al. Fibrin matrices with affinity-based delivery systems and neurotrophic factors promote functional nerve regeneration. Biotechnol Bioeng. 2010;106(6):970–9.PubMedCrossRef

54.

Evans PJ, Midha R, Mackinnon SE. The peripheral nerve allograft: a comprehensive review of regeneration and neuroimmunology. Prog Neurobiol. 1994;43(3):187–233.PubMedCrossRef

55.

Tung TH. Tacrolimus (FK506): safety and applications in reconstructive surgery. Hand (N Y). 2010;5(1):1–8.CrossRef

56.

Mackinnon SE, et al. Clinical outcome following nerve allograft transplantation. Plast Reconstr Surg. 2001;107(6):1419–29.PubMedCrossRef

57.

Hall S. Axonal regeneration through acellular muscle grafts. J Anat. 1997;190(Pt 1):57–71.PubMedCrossRef

58.

Glasby MA, et al. Regeneration of the sciatic nerve in rats. The effect of muscle basement membrane. J Bone Joint Surg Br. 1986;68(5):829–33.PubMed

59.

Glasby MA, et al. Degenerated muscle grafts used for peripheral nerve repair in primates. J Hand Surg Br. 1986;11(3):347–51.PubMedCrossRef

60.

Glasby MA, et al. The dependence of nerve regeneration through muscle grafts in the rat on the availability and orientation of basement membrane. J Neurocytol. 1986;15(4):497–510.PubMedCrossRef

61.

Meek MF, et al. Electronmicroscopical evaluation of short-term nerve regeneration through a thin-walled biodegradable poly(DLLA-epsilon-CL) nerve guide filled with modified denatured muscle tissue. Biomaterials. 2001;22(10):1177–85.PubMedCrossRef

62.

Wood MD, et al. Outcome measures of peripheral nerve regeneration. Ann Anat. 2011;193(4):321–33.PubMedCrossRef

63.

Szynkaruk M, et al. Experimental and clinical evidence for use of decellularized nerve allografts in peripheral nerve gap reconstruction. Tissue Eng Part B Rev. 2013;19(1):83–96.PubMedCrossRef

64.

Mackinnon SE, et al. The peripheral nerve allograft: an assessment of regeneration in the immunosuppressed host. Plast Reconstr Surg. 1987;79(3):436–46.PubMedCrossRef

65.

Ide C, Osawa T, Tohyama K. Nerve regeneration through allogeneic nerve grafts, with special reference to the role of the Schwann cell basal lamina. Prog Neurobiol. 1990;34(1):1–38.PubMedCrossRef

66.

Mackinnon SE, et al. Peripheral nerve allograft: an immunological assessment of pretreatment methods. Neurosurgery. 1984;14(2):167–71.PubMedCrossRef

67.

Mackinnon SE, et al. Peripheral nerve allograft: an assessment of regeneration across pretreated nerve allografts. Neurosurgery. 1984;15(5):690–3.PubMedCrossRef

68.

Gulati AK, Cole GP. Nerve graft immunogenicity as a factor determining axonal regeneration in the rat. J Neurosurg. 1990;72(1):114–22.PubMedCrossRef

69.

Evans PJ, et al. Cold preserved nerve allografts: changes in basement membrane, viability, immunogenicity, and regeneration. Muscle Nerve. 1998;21(11):1507–22.PubMedCrossRef

70.

Hudson TW, et al. Optimized acellular nerve graft is immunologically tolerated and supports regeneration. Tissue Eng. 2004;10(11–12):1641–51.PubMedCrossRef

71.

Hess JR, et al. Use of cold-preserved allografts seeded with autologous Schwann cells in the treatment of a long-gap peripheral nerve injury. Plast Reconstr Surg. 2007;119(1):246–59.PubMedCrossRef

72.

Moradzadeh A, et al. The impact of motor and sensory nerve architecture on nerve regeneration. Exp Neurol. 2008;212(2):370–6.PubMedCrossRef

73.

Zalewski AA, Gulati AK. Evaluation of histocompatibility as a factor in the repair of nerve with a frozen nerve allograft. J Neurosurg. 1982;56(4):550–4.PubMedCrossRef

74.

Gulati AK, Cole GP. Immunogenicity and regenerative potential of acellular nerve allografts to repair peripheral nerve in rats and rabbits. Acta Neurochir (Wien). 1994;126(2–4):158–64.PubMedCrossRef

75.

Osawa T, Tohyama K, Ide C. Allogeneic nerve grafts in the rat, with special reference to the role of Schwann cell basal laminae in nerve regeneration. J Neurocytol. 1990;19(6):833–49.PubMedCrossRef

76.

Danielsen N, et al. Predegeneration enhances regeneration into acellular nerve grafts. Brain Res. 1995;681(1–2):105–8.PubMedCrossRef

77.

Johnson PC, et al. Preparation of cell-free extracellular matrix from human peripheral nerve. Muscle Nerve. 1982;5(4):335–44.PubMedCrossRef

78.

Levi AD, et al. Cold storage of peripheral nerves: an in vitro assay of cell viability and function. Glia. 1994;10(2):121–31.PubMedCrossRef

79.

Sondell M, Lundborg G, Kanje M. Regeneration of the rat sciatic nerve into allografts made acellular through chemical extraction. Brain Res. 1998;795(1–2):44–54.PubMedCrossRef

80.

Hudson TW, Liu SY, Schmidt CE. Engineering an improved acellular nerve graft via optimized chemical processing. Tissue Eng. 2004;10(9–10):1346–58.PubMed

81.

Fox IK, et al. Prolonged cold-preservation of nerve allografts. Muscle Nerve. 2005;31(1):59–69.PubMedCrossRef

82.

Yang LJ, et al. Sialidase enhances spinal axon outgrowth in vivo. Proc Natl Acad Sci U S A. 2006;103(29):11057–62.PubMedCrossRef

83.

Graham JB, et al. Chondroitinase applied to peripheral nerve repair averts retrograde axonal regeneration. Exp Neurol. 2007;203(1):185–95.PubMedCrossRef

84.

Neubauer D, Graham JB, Muir D. Chondroitinase treatment increases the effective length of acellular nerve grafts. Exp Neurol. 2007;207(1):163–70.PubMedCrossRef

85.

Whitlock EL, et al. Processed allografts and type I collagen conduits for repair of peripheral nerve gaps. Muscle Nerve. 2009;39(6):787–99.

86.

Moore AM, et al. Acellular nerve allografts in peripheral nerve regeneration: a comparative study. Muscle Nerve. 2011;44(2):221–34.PubMedCrossRef

87.

Santosa KB, et al. Nerve allografts supplemented with Schwann cells overexpressing glial-cell-line-derived neurotrophic factor. Muscle Nerve. 2013;47(2):213–23.PubMedCrossRef

88.

Lai C. Peripheral glia: Schwann cells in motion. Curr Biol. 2005;15(9):R332–4.PubMedCrossRef

89.

Lyons DA, et al. erbb3 and erbb2 are essential for Schwann cell migration and myelination in zebrafish. Curr Biol. 2005;15(6):513–24.PubMedCrossRef

90.

Kazakova N, et al. A screen for mutations in zebrafish that affect myelin gene expression in Schwann cells and oligodendrocytes. Dev Biol. 2006;297(1):1–13.PubMedCrossRef

91.

Martini R, Xin Y, Schachner M. Restricted localization of L1 and N-CAM at sites of contact between Schwann cells and neurites in culture. Glia. 1994;10(1):70–4.PubMedCrossRef

92.

Akassoglou K, et al. Fibrin inhibits peripheral nerve remyelination by regulating Schwann cell differentiation. Neuron. 2002;33(6):861–75.PubMedCrossRef

93.

Mosahebi A, et al. Effect of allogeneic Schwann cell transplantation on peripheral nerve regeneration. Exp Neurol. 2002;173(2):213–23.PubMedCrossRef

94.

Bunge RP, Bunge MB, Eldridge CF. Linkage between axonal ensheathment and basal lamina production by Schwann cells. Annu Rev Neurosci. 1986;9:305–28.PubMedCrossRef

95.

Friedman B, et al. Regulation of ciliary neurotrophic factor expression in myelin-related Schwann cells in vivo. Neuron. 1992;9(2):295–305.PubMedCrossRef

96.

Bunge RP. The role of the Schwann cell in trophic support and regeneration. J Neurol. 1994;242(1 Suppl 1):S19–21.PubMedCrossRef

97.

Levi AD, Bunge RP. Studies of myelin formation after transplantation of human Schwann cells into the severe combined immunodeficient mouse. Exp Neurol. 1994;130(1):41–52.PubMedCrossRef

98.

Araki T, Milbrandt J. Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth. Neuron. 1996;17(2):353–61.PubMedCrossRef

99.

Hall SM. The effect of inhibiting Schwann cell mitosis on the reinnervation of acellular autografts in the peripheral nervous system of the mouse. Neuropathol Appl Neurobiol. 1986;12(4):401–14.PubMedCrossRef

100.

Hall SM. Regeneration in cellular and acellular autografts in the peripheral nervous system. Neuropathol Appl Neurobiol. 1986;12(1):27–46.PubMedCrossRef

101.

Wood PM. Separation of functional Schwann cells and neurons from normal peripheral nerve tissue. Brain Res. 1976;115(3):361–75.PubMedCrossRef

102.

Brockes JP, Fields KL, Raff MC. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res. 1979;165(1):105–18.PubMedCrossRef

103.

Paino CL, et al. Regrowth of axons in lesioned adult rat spinal cord: promotion by implants of cultured Schwann cells. J Neurocytol. 1994;23(7):433–52.PubMedCrossRef

104.

Fortun J, Hill CE, Bunge MB. Combinatorial strategies with Schwann cell transplantation to improve repair of the injured spinal cord. Neurosci Lett. 2009;456(3):124–32.PubMedCrossRef

105.

Guenard V, et al. Syngeneic Schwann cells derived from adult nerves seeded in semipermeable guidance channels enhance peripheral nerve regeneration. J Neurosci. 1992;12(9):3310–20.PubMed

106.

Kim DH, et al. Labeled Schwann cell transplants versus sural nerve grafts in nerve repair. J Neurosurg. 1994;80(2):254–60.PubMedCrossRef

107.

Levi AD, et al. The functional characteristics of Schwann cells cultured from human peripheral nerve after transplantation into a gap within the rat sciatic nerve. J Neurosci. 1994;14(3 Pt 1):1309–19.PubMed

108.

Ogden MA, et al. Safe injection of cultured Schwann cells into peripheral nerve allografts. Microsurgery. 2000;20(7):314–23.PubMedCrossRef

109.

Brenner MJ, et al. Effects of Schwann cells and donor antigen on long-nerve allograft regeneration. Microsurgery. 2005;25(1):61–70.PubMedCrossRef

110.

Fox IK, et al. Schwann cell injection of cold-preserved nerve allografts. Microsurgery. 2005;25(6):502–7.PubMedCrossRef

111.

Hu J, et al. Repair of extended peripheral nerve lesions in rhesus monkeys using acellular allogenic nerve grafts implanted with autologous mesenchymal stem cells. Exp Neurol. 2007;204(2):658–66.PubMedCrossRef

112.

Aszmann OC, et al. Bridging critical nerve defects through an acellular homograft seeded with autologous Schwann cells obtained from a regeneration neuroma of the proximal stump. J Reconstr Microsurg. 2008;24(3):151–8.PubMedCrossRef

113.

Jessen KR, Mirsky R, Morgan L. Axonal signals regulate the differentiation of non-myelin-forming Schwann cells: an immunohistochemical study of galactocerebroside in transected and regenerating nerves. J Neurosci. 1987;7(10):3362–9.PubMed

114.

Seilheimer B, Schachner M. Studies of adhesion molecules mediating interactions between cells of peripheral nervous system indicate a major role for L1 in mediating sensory neuron growth on Schwann cells in culture. J Cell Biol. 1988;107(1):341–51.PubMedCrossRef

115.

Acheson A, et al. Detection of brain-derived neurotrophic factor-like activity in fibroblasts and Schwann cells: inhibition by antibodies to NGF. Neuron. 1991;7(2):265–75.PubMedCrossRef

116.

Bunge RP. Expanding roles for the Schwann cell: ensheathment, myelination, trophism and regeneration. Curr Opin Neurobiol. 1993;3(5):805–9.PubMedCrossRef

117.

Xu XM, et al. Axonal regeneration into Schwann cell-seeded guidance channels grafted into transected adult rat spinal cord. J Comp Neurol. 1995;351(1):145–60.PubMedCrossRef

118.

Li Y, Raisman G. Integration of transplanted cultured Schwann cells into the long myelinated fiber tracts of the adult spinal cord. Exp Neurol. 1997;145(2 Pt 1):397–411.PubMedCrossRef

119.

Fansa H, et al. Successful implantation of Schwann cells in acellular muscles. J Reconstr Microsurg. 1999;15(1):61–5.PubMedCrossRef

120.

Morrissey TK, Kleitman N, Bunge RP. Isolation and functional characterization of Schwann cells derived from adult peripheral nerve. J Neurosci. 1991;11(8):2433–42.PubMed

121.

Levi AD, et al. The influence of heregulins on human Schwann cell proliferation. J Neurosci. 1995;15(2):1329–40.PubMed

122.

Mathon NF, et al. Lack of replicative senescence in normal rodent glia. Science. 2001;291(5505):872–5.PubMedCrossRef

123.

Emery E, et al. Assessment of the malignant potential of mitogen stimulated human Schwann cells. J Peripher Nerv Syst. 1999;4(2):107–16.PubMed

124.

Atkins S, et al. Scarring impedes regeneration at sites of peripheral nerve repair. Neuroreport. 2006;17(12):1245–9.PubMedCrossRef

125.

Needham LK, Tennekoon GI, McKhann GM. Selective growth of rat Schwann cells in neuron- and serum-free primary culture. J Neurosci. 1987;7(1):1–9.PubMed

126.

Levi AD. Characterization of the technique involved in isolating Schwann cells from adult human peripheral nerve. J Neurosci Methods. 1996;68(1):21–6.PubMedCrossRef

127.

Keilhoff G, et al. In vivo predegeneration of peripheral nerves: an effective technique to obtain activated Schwann cells for nerve conduits. J Neurosci Methods. 1999;89(1):17–24.PubMedCrossRef

128.

Verdu E, et al. Expansion of adult Schwann cells from mouse predegenerated peripheral nerves. J Neurosci Methods. 2000;99(1–2):111–7.PubMedCrossRef

129.

Calderon-Martinez D, et al. Schwann cell-enriched cultures from adult human peripheral nerve: a technique combining short enzymatic dissociation and treatment with cytosine arabinoside (Ara-C). J Neurosci Methods. 2002;114(1):1–8.PubMedCrossRef

130.

Vroemen M, Weidner N. Purification of Schwann cells by selection of p75 low affinity nerve growth factor receptor expressing cells from adult peripheral nerve. J Neurosci Methods. 2003;124(2):135–43.PubMedCrossRef

131.

Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292(5819):154–6.PubMedCrossRef

132.

Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A. 1981;78(12):7634–8.PubMedCrossRef

133.

Itskovitz-Eldor J, et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med. 2000;6(2):88–95.PubMed

134.

Nussbaum J, et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. Faseb J. 2007;21(7):1345–57.PubMedCrossRef

135.

Amariglio N, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009;6(2):e1000029.PubMedCrossRef

136.

Bain G, et al. Embryonic stem cells express neuronal properties in vitro. Dev Biol. 1995;168(2):342–57.PubMedCrossRef

137.

Cui L, et al. Transplantation of embryonic stem cells improves nerve repair and functional recovery after severe sciatic nerve axotomy in rats. Stem Cells. 2008;26(5):1356–65.PubMedCrossRef

138.

Willerth SM, et al. The effects of soluble growth factors on embryonic stem cell differentiation inside of fibrin scaffolds. Stem Cells. 2007;25(9):2235–44.PubMedCrossRef

139.

Ziegler L, et al. Efficient generation of Schwann cells from human embryonic stem cell-derived neurospheres. Stem Cell Rev. 2011;7(2):394–403.PubMedCrossRef

140.

Liu Q, et al. Human neural crest stem cells derived from human ESCs and induced pluripotent stem cells: induction, maintenance, and differentiation into functional Schwann cells. Stem Cells Transl Med. 2012;1(4):266–78.PubMedCrossRef

141.

Lee EJ, et al. Regeneration of peripheral nerves by transplanted sphere of human mesenchymal stem cells derived from embryonic stem cells. Biomaterials. 2012;33(29):7039–46.PubMedCrossRef

142.

Johnson PJ, et al. Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI. Soft Matter. 2010;6(20):5127–37.PubMedCrossRef

143.

Dawson TM, et al. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci U S A. 1993;90(21):9808–12.PubMedCrossRef

144.

Gold BG, Katoh K, Storm-Dickerson T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J Neurosci. 1995;15(11):7509–16.PubMed

145.

Madsen JR, et al. Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats. Exp Neurol. 1998;154(2):673–83.PubMedCrossRef

146.

Doolabh VB, Mackinnon SE. FK506 accelerates functional recovery following nerve grafting in a rat model. Plast Reconstr Surg. 1999;103(7):1928–36.PubMedCrossRef

147.

Gold BG. FK506 and the role of the immunophilin FKBP-52 in nerve regeneration. Drug Metab Rev. 1999;31(3):649–63.PubMedCrossRef

148.

Lee M, et al. FK506 promotes functional recovery in crushed rat sciatic nerve. Muscle Nerve. 2000;23(4):633–40.PubMedCrossRef

149.

Feng FY, et al. FK506 rescues peripheral nerve allografts in acute rejection. J Neurotrauma. 2001;18(2):217–29.PubMedCrossRef

150.

Chunasuwankul R, et al. Low dose discontinued FK506 treatment enhances peripheral nerve regeneration. Int Surg. 2002;87(4):274–8.PubMed

151.

Udina E, et al. Bimodal dose-dependence of FK506 on the rate of axonal regeneration in mouse peripheral nerve. Muscle Nerve. 2002;26(3):348–55.PubMedCrossRef

152.

Sobol JB, et al. Effects of delaying FK506 administration on neuroregeneration in a rodent model. J Reconstr Microsurg. 2003;19(2):113–8.PubMedCrossRef

153.

Udina E, et al. FK506 enhances reinnervation by regeneration and by collateral sprouting of peripheral nerve fibers. Exp Neurol. 2003;183(1):220–31.PubMedCrossRef

154.

Udina E, Gold BG, Navarro X. Comparison of continuous and discontinuous FK506 administration on autograft or allograft repair of sciatic nerve resection. Muscle Nerve. 2004;29(6):812–22.PubMedCrossRef

155.

Brenner MJ, et al. FK506 and anti-CD40 ligand in peripheral nerve allotransplantation. Restor Neurol Neurosci. 2005;23(3–4):237–49.PubMed

156.

Jensen JN, et al. Effect of FK506 on peripheral nerve regeneration through long grafts in inbred swine. Ann Plast Surg. 2005;54(4):420–7.PubMedCrossRef

157.

Sun HH, et al. Geldanamycin accelerated peripheral nerve regeneration in comparison to FK-506 in vivo. Neuroscience. 2012;223:114–23.PubMedCrossRef

158.

Yan Y, et al. Efficacy of short-term FK506 administration on accelerating nerve regeneration. Neurorehabil Neural Repair. 2012;26(6):570–80.PubMedCrossRef

159.

Pittenger MF, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–7.PubMedCrossRef

160.

Sheng Z, et al. Regeneration of functional sweat gland-like structures by transplanted differentiated bone marrow mesenchymal stem cells. Wound Repair Regen. 2009;17(3):427–35.PubMedCrossRef

161.

Orlic D, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410(6829):701–5.PubMedCrossRef

162.

Oswald J, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. 2004;22(3):377–84.PubMedCrossRef

163.

Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A. 1999;96(19):10711–6.PubMedCrossRef

164.

Hofstetter CP, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A. 2002;99(4):2199–204.PubMedCrossRef

165.

Jiang Y, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418(6893):41–9.PubMedCrossRef

166.

Tohill M, et al. Rat bone marrow mesenchymal stem cells express glial markers and stimulate nerve regeneration. Neurosci Lett. 2004;362(3):200–3.PubMedCrossRef

167.

Shah NM, et al. Glial growth factor restricts mammalian neural crest stem cells to a glial fate. Cell. 1994;77(3):349–60.PubMedCrossRef

168.

Caddick J, et al. Phenotypic and functional characteristics of mesenchymal stem cells differentiated along a Schwann cell lineage. Glia. 2006;54(8):840–9.PubMedCrossRef

169.

Keilhoff G, et al. Transdifferentiation of mesenchymal stem cells into Schwann cell-like myelinating cells. Eur J Cell Biol. 2006;85(1):11–24.PubMedCrossRef

170.

Keilhoff G, et al. Peripheral nerve tissue engineering: autologous Schwann cells vs. transdifferentiated mesenchymal stem cells. Tissue Eng. 2006;12(6):1451–65.PubMedCrossRef

171.

Keilhoff G, et al. Transdifferentiated mesenchymal stem cells as alternative therapy in supporting nerve regeneration and myelination. Cell Mol Neurobiol. 2006;26(7–8):1235–52.PubMed

172.

Mahay D, Terenghi G, Shawcross SG. Schwann cell mediated trophic effects by differentiated mesenchymal stem cells. Exp Cell Res. 2008;314(14):2692–701.PubMedCrossRef

173.

Mahay D, Terenghi G, Shawcross SG. Growth factors in mesenchymal stem cells following glial-cell differentiation. Biotechnol Appl Biochem. 2008;51(Pt 4):167–76.PubMedCrossRef

174.

Brohlin M, et al. Characterization of human mesenchymal stem cells following differentiation into Schwann cell-like cells. Neurosci Res. 2009;64(1):41–9.PubMedCrossRef

175.

Song L, Tuan RS. Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. Faseb J. 2004;18(9):980–2.PubMed

176.

Krabbe C, Zimmer J, Meyer M. Neural transdifferentiation of mesenchymal stem cells—a critical review. APMIS. 2005;113(11–12):831–44.PubMedCrossRef

177.

Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair—current views. Stem Cells. 2007;25(11):2896–2902.PubMedCrossRef

178.

Shea GK, et al. Bone marrow-derived Schwann cells achieve fate commitment—a prerequisite for remyelination therapy. Exp Neurol. 2010;224(2):448–58.PubMedCrossRef

179.

Hollenberg CH, Vost A. Regulation of DNA synthesis in fat cells and stromal elements from rat adipose tissue. J Clin Invest. 1969;47(11):2485–98.PubMedCrossRef

180.

Van RL, Bayliss CE, Roncari DA. Cytological and enzymological characterization of adult human adipocyte precursors in culture. J Clin Invest. 1976;58(3):699–704.PubMedCrossRef

181.

Gimble J, Guilak F. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy. 2003;5(5):362–9.PubMedCrossRef

182.

Strem BM, et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med. 2005;54(3):132–41.PubMedCrossRef

183.

De Ugarte DA, et al. Comparison of multilineage cells from human adipose tissue and bone marrow. Cells Tissues Organs. 2003;174(3):101–9.PubMedCrossRef

184.

Aust L, et al. Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy. 2004;6(1):7–14.PubMedCrossRef

185.

Kingham PJ, et al. Adipose-derived stem cells differentiate into a Schwann cell phenotype and promote neurite outgrowth in vitro. Exp Neurol. 2007;207(2):267–74.PubMedCrossRef

186.

Xu Y, et al. Myelin-forming ability of Schwann cell-like cells induced from rat adipose-derived stem cells in vitro. Brain Res. 2008;1239:49–55.PubMedCrossRef

187.

Radtke C, et al. Peripheral glial cell differentiation from neurospheres derived from adipose mesenchymal stem cells. Int J Dev Neurosci. 2009;27(8):817–23.PubMedCrossRef

188.

Chi GF, et al. Schwann cells differentiated from spheroid-forming cells of rat subcutaneous fat tissue myelinate axons in the spinal cord injury. Exp Neurol. 2010;222(2):304–17.PubMedCrossRef

189.

Mantovani C, et al. Bone marrow- and adipose-derived stem cells show expression of myelin mRNAs and proteins. Regen Med. 2010;5(3):403–10.PubMedCrossRef

190.

di Summa PG, et al. Long-term in vivo regeneration of peripheral nerves through bioengineered nerve grafts. Neuroscience. 2011;181:278–91.PubMedCrossRef

191.

Erba P, et al. Regeneration potential and survival of transplanted undifferentiated adipose tissue-derived stem cells in peripheral nerve conduits. J Plast Reconstr Aesthet Surg. 2010;63(12):e811–7.PubMedCrossRef

192.

Kruger GM, et al. Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness. Neuron. 2002;35(4):657–69.PubMedCrossRef

193.

Toma JG, et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol. 2001;3(9):778–84.PubMedCrossRef

194.

Li L, et al. Nestin expression in hair follicle sheath progenitor cells. Proc Natl Acad Sci U S A. 2003;100(17):9958–61.PubMedCrossRef

195.

Fernandes KJ, et al. A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol. 2004;6(11):1082–13.PubMedCrossRef

196.

Sieber-Blum M, et al. Pluripotent neural crest stem cells in the adult hair follicle. Dev Dyn. 2004;231(2):258–69.PubMedCrossRef

197.

Amoh Y, et al. Multipotent nestin-positive, keratin-negative hair-follicle bulge stem cells can form neurons. Proc Natl Acad Sci U S A. 2005;102(15):5530–4.PubMedCrossRef

198.

Amoh Y, et al. Implanted hair follicle stem cells form Schwann cells that support repair of severed peripheral nerves. Proc Natl Acad Sci U S A. 2005;102(49):17734–8.PubMedCrossRef

199.

McKenzie IA, et al. Skin-derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system. J Neurosci. 2006;26(24):6651–60.PubMedCrossRef

200.

Walsh S, et al. Supplementation of acellular nerve grafts with skin derived precursor cells promotes peripheral nerve regeneration. Neuroscience. 2009;164(3):1097–107.PubMedCrossRef

201.

Walsh SK, et al. Fate of stem cell transplants in peripheral nerves. Stem Cell Res. 2012;8(2):226–38.PubMedCrossRef

202.

Johnson PJ, et al. Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplant. 2010;19(1):89–101.PubMedCrossRef

203.

Trupp M, et al. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J Cell Biol. 1995;130(1):137–48.PubMedCrossRef

204.

Naveilhan P, ElShamy WM, Ernfors P. Differential regulation of mRNAs for GDNF and its receptors Ret and GDNFR alpha after sciatic nerve lesion in the mouse. Eur J Neurosci. 1997;9(7):1450–60.PubMedCrossRef

205.

Hammarberg H, et al. Differential regulation of trophic factor receptor mRNAs in spinal motoneurons after sciatic nerve transection and ventral root avulsion in the rat. J Comp Neurol. 2000;426(4):587–601.PubMedCrossRef

206.

Sun Y, et al. Effects of embryonic neural stem cells and glial cell line-derived neurotrophic factor in the repair of spinal cord injury. Sheng Li Xue Bao. 2003;55(3):349–54.PubMed

207.

Lie DC, Weis J. GDNF expression is increased in denervated human skeletal muscle. Neurosci Lett. 1998;250(2):87–90.PubMedCrossRef

208.

Zhao C, et al. NGF, BDNF, NT-3, and GDNF mRNA expression in rat skeletal muscle following denervation and sensory protection. J Neurotrauma. 2004;21(10):1468–78.PubMedCrossRef

209.

Eggers R, et al. A spatio-temporal analysis of motoneuron survival, axonal regeneration and neurotrophic factor expression after lumbar ventral root avulsion and implantation. Exp Neurol. 2010;223(1):207–20.PubMedCrossRef

210.

Hoke A, et al. A decline in glial cell-line-derived neurotrophic factor expression is associated with impaired regeneration after long-term Schwann cell denervation. Exp Neurol. 2002;173(1):77–85.PubMedCrossRef

211.

Boyd JG, Gordon T. Glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor sustain the axonal regeneration of chronically axotomized motoneurons in vivo. Exp Neurol. 2003;183(2):610–9.PubMedCrossRef

212.

Boyd JG, Gordon T. Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury. Mol Neurobiol. 2003;27(3):277–324.PubMedCrossRef

213.

Santos AR Jr, et al. Differential Schwann cell migration in adult and old mice: an in vitro study. Brain Res. 2000;881(1):73–6.PubMedCrossRef

214.

Young C, et al. Nerve growth factor and neurotrophin-3 affect functional recovery following peripheral nerve injury differently. Restor Neurol Neurosci. 2001;18(4):167–75.PubMed

215.

Wong LF, et al. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications. Hum Gene Ther. 2006;17(1):1–9.PubMedCrossRef

216.

Hendriks WT, et al. Lentiviral vector-mediated reporter gene expression in avulsed spinal ventral root is short-term, but is prolonged using an immune "stealth" transgene. Restor Neurol Neurosci. 2007;25(5–6):585–99.PubMed

217.

Tannemaat MR, et al. Differential effects of lentiviral vector-mediated overexpression of nerve growth factor and glial cell line-derived neurotrophic factor on regenerating sensory and motor axons in the transected peripheral nerve. Eur J Neurosci. 2008;28(8):1467–79.PubMedCrossRef

218.

Blits B, et al. Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor. Exp Neurol. 2004;189(2):303–16.PubMedCrossRef

219.

Shakhbazau A, et al. Early regenerative effects of NGF-transduced Schwann cells in peripheral nerve repair. Mol Cell Neurosci. 2012;50(1):103–12.PubMedCrossRef

220.

Hare GM, et al. Walking track analysis: a long-term assessment of peripheral nerve recovery. Plast Reconstr Surg. 1992;89(2):251–8.PubMedCrossRef

221.

Whitlock EL, et al. Processed allografts and type I collagen conduits for repair of peripheral nerve gaps. Muscle Nerve. 2009;39(6):787–99.PubMedCrossRef

Titel: Tissue engineered constructs for peripheral nerve surgery
verfasst von: Asst. Prof. P. J. Johnson, PhD
M. D. Wood, PhD
A. M . Moore, MD
S. E. Mackinnon, MD
Publikationsdatum: 01.06.2013
Verlag: Springer Vienna
Erschienen in: European Surgery / Ausgabe 3/2013
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI: https://doi.org/10.1007/s10353-013-0205-0

Springer Medizin Österreich

Summary

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

Erratum to: Effects of everolimus on hepatic ischemia/reperfusion injury in an experimental rat model

Concentrated sugar belongs to the museum

Applications of tissue engineering in modern laryngology

Fatal arterial complications following ultrasound-guided attempt of internal jugular vein catheterization

Tissue engineering and its potential use in surgery

Gemcitabine-based neoadjuvant chemotherapy for locally advanced pancreatic cancer does not affect mortality and morbidity after pancreatic resection

Applications of tissue engineering in modern laryngology 